MarketPeel
Insider Trading Intelligence
RL

Rtw Investments, Lp

MIST
10% OWNER · MILESTONE PHARMACEUTICALS INC. · CIK 0001493215
FILING MIX · LIFETIME68%/32%
BUYS
53
SELLS
25
TOTAL VALUE
$375.67M
COMPANIES
7
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
33,066,580
AVG SELL PX
$13.46
TRADE KIND
SHOWING 78 / 78
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Rtw Investments, Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+44.44%-1.48%-0.04%-1.44%-2.80%
14d18+38.89%-0.37%-0.38%+0.01%-2.34%
30d18+38.89%-4.12%+2.33%-5.50%+3.76%
60d18+44.44%-10.24%+4.70%-14.94%-6.66%
90d18(1 pending)+58.82%-11.16%+8.03%-19.20%-16.83%
180d18(1 pending)+58.82%-6.25%+16.62%-22.87%-20.36%
1y18(2 pending)+43.75%-25.69%+24.90%-50.59%-69.46%
2y18(4 pending)+28.57%-42.57%+37.54%-80.11%-90.55%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MIST · 3,256,102 shares · as of Mar 22, 2023
02,129,5644,259,1296,388,6938,518,2572020202120222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 53 buys / 25 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
1,250,032$0.00$1259,556,095Apr 27, 2026Apr 29, 2026View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
SALE
32$4.13$1329,556,063Apr 27, 2026Apr 29, 2026View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
SALE
1,250,032$2.75$3.44M2,386,331Apr 27, 2026Apr 29, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
2,026,8200Apr 20, 2026Apr 22, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
500,000$16.00$8.00M10,776,820Apr 20, 2026Apr 22, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
10,276,82010,276,820Apr 20, 2026Apr 22, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
8,250,0000Apr 20, 2026Apr 22, 2026View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
96,896$1.67$161.8K298,992Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
767,848767,848Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
96,89696,896Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
991,544$1.67$1.66M3,138,798Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
991,544991,544Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
767,848$1.67$1.28M2,427,089Nov 12, 2025Nov 13, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
37,863$3.35$126.8K202,096Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
SALE
$2,756,117.00Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
$2,117,044.00Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
SALE
$2,117,044.000Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
SALE
$126,839.00Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
631,954$3.35$2.12M1,659,241Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
$126,839.00Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
822,722$3.35$2.76M2,147,254Nov 5, 2025Nov 7, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
$2,756,117.00Nov 5, 2025Nov 7, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
10Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
59,000$3.11$183.2K18,188,457Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
10Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
41,000$19.09$782.8K18,229,457Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
1,000,000$40.03$40.03M19,188,457Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
1,000,000$3.11$3.10M18,188,457Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
59,000$17.81$1.05M18,247,457Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
10Sep 19, 2025Sep 23, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
41,000$3.11$127.3K18,188,457Sep 19, 2025Sep 23, 2025View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
3,636,363$2.75$10.00M3,636,363Aug 4, 2025Aug 6, 2025View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
49,900$2.99$149.2K8,306,063Apr 30, 2025May 1, 2025View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
50,000$2.53$126.5K8,256,163Apr 29, 2025Apr 29, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
822,722$3.35$2.76M1,324,532Apr 16, 2025Apr 17, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
SALE
$5,000,000.00Apr 16, 2025Apr 17, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
37,863$3.35$126.8K164,233Apr 16, 2025Apr 17, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASE
631,954$3.35$2.12M1,027,287Apr 16, 2025Apr 17, 2025View →
ALUR
ALLURION TECHNOLOGIES, INC.
PURCHASEGRANT
Stock grant
$5,000,000.00Apr 16, 2025Apr 17, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
400,000$12.49$5.00M3,526,955Dec 12, 2024Dec 16, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
3,126,955$15.99$50.00M3,126,955Sep 15, 2023Sep 19, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
500,000$15.87$7.93M18,157,605Aug 28, 2023Aug 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
500,000$22.05$11.03M17,657,605Aug 28, 2023Aug 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
500,000$15.87$7.93M18,157,605Aug 28, 2023Aug 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
500,000$22.05$11.03M18,657,605Aug 28, 2023Aug 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
10Aug 28, 2023Aug 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
10Aug 28, 2023Aug 30, 2023View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
502,1335,620,645Apr 13, 2023May 5, 2023View →
MIST
MILESTONE PHARMACEUTICALS INC.
SALE
1,059,0003,256,102Mar 22, 2023Mar 24, 2023View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
2,310,0005,118,512Jan 26, 2023Jan 30, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
11Dec 23, 2022Dec 23, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
11Dec 22, 2022Dec 22, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
61,70561,705Dec 1, 2022Apr 5, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
529,03818,157,605Dec 1, 2022Apr 5, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
1,355,932$14.75$20.00M17,628,567Oct 6, 2022Oct 11, 2022View →
MIST
MILESTONE PHARMACEUTICALS INC.
SALE
1,557,346$8.71$13.56M4,315,102Sep 7, 2022Sep 9, 2022View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
1,557,346$8.71$13.56M4,315,102Sep 7, 2022Sep 9, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
11,000,000May 19, 2022Apr 5, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
812,516$32.48$26.39M16,272,635Aug 27, 2021Aug 31, 2021View →
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASE
800,000$18.00$14.40M4,795,000Aug 4, 2021Aug 6, 2021View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
910,746$5.48$4.99M8,518,257May 21, 2021May 24, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
725,000$40.03$29.02M15,460,119May 11, 2021May 13, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
11,000,000May 11, 2021May 13, 2021View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
450,000$29.98$13.49M2,013,601May 7, 2021May 7, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
1,344,92516,185,119Mar 24, 2021Mar 29, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
247,720$56.00$13.87M17,530,044Dec 10, 2020Dec 14, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
952,380$5.24$4.99M7,607,511Oct 27, 2020Oct 29, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
6,655,131$3.75$24.96M6,655,131Jul 22, 2020Jul 24, 2020View →
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASE
950,000$18.00$17.10M3,995,000Jun 16, 2020Jun 16, 2020View →
RNA
ATRIUM THERAPEUTICS, INC.
SALE
6,423,4310Jun 16, 2020Jun 16, 2020View →
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASE
3,045,0003,045,000Jun 16, 2020Jun 16, 2020View →
RNA
ATRIUM THERAPEUTICS, INC.
SALE
3,995,0000Jun 11, 2020Aug 6, 2021View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
5,870$10.87$63.8K4,315,102Mar 19, 2020Mar 19, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
2,705$10.36$28.0K4,309,232Mar 18, 2020Mar 19, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
78,263$18.95$1.48M4,306,527Mar 2, 2020Mar 19, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
270,000$16.25$4.39M4,228,264Jan 13, 2020Jan 13, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
21,438$15.50$332.3K3,958,264Dec 31, 2019Jan 2, 2020View →
MIST
MILESTONE PHARMACEUTICALS INC.
PURCHASE
1,333$15.48$20.6K3,936,826Dec 30, 2019Jan 2, 2020View →
Other insiders · MIST
Loading peer insiders…
About this filer
CIK 0001493215
ROLE
10% Owner
PRIMARY
MIST
COMPANIES
7
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001493215DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback